News: AstraZeneca, Novartis Join in the Land Grab in Russia


Jun 17, 2011

Both AstraZeneca and Novartis this week clarified their plans for developing and manufacturing drugs within Russia, in accordance with the Russian government's desire that drug manufacturers who wish to sell products within the country bring technology and jobs there as well. One analyst (see first link below) calls these moves part of a "land grab" by global pharma companies for turf within the Russian market.

AZ Announces Strategy for Russia

Novartis Begins Construction in St. Petersburg

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments